Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avidity Biosciences (RNA) Other financing activities (2019 - 2022)

Historic Other financing activities for Avidity Biosciences (RNA) over the last 4 years, with Q3 2022 value amounting to $1.2 million.

  • Avidity Biosciences' Other financing activities fell 8829.53% to $1.2 million in Q3 2022 from the same period last year, while for Sep 2022 it was $9.8 million, marking a year-over-year decrease of 574.09%. This contributed to the annual value of $17.1 million for FY2021, which is 2901.02% down from last year.
  • As of Q3 2022, Avidity Biosciences' Other financing activities stood at $1.2 million, which was down 8829.53% from $1.2 million recorded in Q2 2022.
  • Over the past 5 years, Avidity Biosciences' Other financing activities peaked at $22.5 million during Q2 2020, and registered a low of $10000.0 during Q2 2021.
  • In the last 4 years, Avidity Biosciences' Other financing activities had a median value of $1.2 million in 2022 and averaged $4.4 million.
  • In the last 5 years, Avidity Biosciences' Other financing activities crashed by 9995.55% in 2021 and then surged by 1174000.0% in 2022.
  • Over the past 4 years, Avidity Biosciences' Other financing activities (Quarter) stood at $17000.0 in 2019, then skyrocketed by 7817.65% to $1.3 million in 2020, then surged by 394.58% to $6.7 million in 2021, then tumbled by 81.73% to $1.2 million in 2022.
  • Its Other financing activities stands at $1.2 million for Q3 2022, versus $1.2 million for Q2 2022 and $745000.0 for Q1 2022.